Abstract
To identify better those subgroups of pacemaker recipients who will benefit from dual chamber pacing, 19 patients with DDD pacemakers that were physiologically paced were entered into a blinded, randomized protocol comparing long-term VVI versus DDD pacing. Patients were evaluated in each of the pacing modes for exercise performance, cardiac chamber size, cardiac output, functional status and health perception. Eight patients (42%) insisted on early crossover, from VVI to DDD pacing, after only 1.8 ± 1.4 weeks because of symptoms consistent with pacemaker syndrome. Overall, 12 patients preferred DDD pacing and no patient preferred VVI pacing (p = 0.001). Percent fractional shortening (30 ± 8 vs 24 ± 6%, p = 0.009) and cardiac output (6.3 ± 2.6 vs 4.4 ± 2.2 liters/min, p = 0.0001) where significantly greater in the DDD mode. Exercise duration was greater during DDD compared with VVI pacing (11.3 ± 3.7 vs 10.1 ±3.7 minutes, p = 0.006). However, it was only in the crossover subgroup that DDD pacing resulted in significant improvement in exercise performance and health perception compared with VVI pacing. This subgroup of patients was characterized by an intrinsic sinus rate of <60 beats/min (4/8 vs 0/11, p = 0.006), ventriculoatrial (VA) conduction (4/8 vs 1/11, p = 0.048), greater increase in exercise peak systolic blood pressure from VVI to DDD mode (21 ± 12 vs 4 ± 13 mm Hg, p = 0.02) and greater improvement in exercise capacity from VVI to DDD pacing (2.2 ± 1.2 vs 0.6 ± 1.4 minutes, p = 0.03) compared with the other 11 patients. A native sinus rate of <60 beats/min or VA conduction was found in 7 of the 8 patients who crossed over, but in only 1 of the 11 patients who tolerated long-term VVI pacing (p = 0.009).
Original language | English (US) |
---|---|
Pages (from-to) | 323-329 |
Number of pages | 7 |
Journal | The American Journal of Cardiology |
Volume | 61 |
Issue number | 4 |
DOIs | |
State | Published - Feb 1 1988 |
Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
}
Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers. / Rediker, Donald E.; Eagle, Kim A.; Homma, Shunichi; Gillam, Linda; Harthorne, J. Warren.
In: The American Journal of Cardiology, Vol. 61, No. 4, 01.02.1988, p. 323-329.Research output: Contribution to journal › Article
TY - JOUR
T1 - Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers
AU - Rediker, Donald E.
AU - Eagle, Kim A.
AU - Homma, Shunichi
AU - Gillam, Linda
AU - Harthorne, J. Warren
PY - 1988/2/1
Y1 - 1988/2/1
N2 - To identify better those subgroups of pacemaker recipients who will benefit from dual chamber pacing, 19 patients with DDD pacemakers that were physiologically paced were entered into a blinded, randomized protocol comparing long-term VVI versus DDD pacing. Patients were evaluated in each of the pacing modes for exercise performance, cardiac chamber size, cardiac output, functional status and health perception. Eight patients (42%) insisted on early crossover, from VVI to DDD pacing, after only 1.8 ± 1.4 weeks because of symptoms consistent with pacemaker syndrome. Overall, 12 patients preferred DDD pacing and no patient preferred VVI pacing (p = 0.001). Percent fractional shortening (30 ± 8 vs 24 ± 6%, p = 0.009) and cardiac output (6.3 ± 2.6 vs 4.4 ± 2.2 liters/min, p = 0.0001) where significantly greater in the DDD mode. Exercise duration was greater during DDD compared with VVI pacing (11.3 ± 3.7 vs 10.1 ±3.7 minutes, p = 0.006). However, it was only in the crossover subgroup that DDD pacing resulted in significant improvement in exercise performance and health perception compared with VVI pacing. This subgroup of patients was characterized by an intrinsic sinus rate of <60 beats/min (4/8 vs 0/11, p = 0.006), ventriculoatrial (VA) conduction (4/8 vs 1/11, p = 0.048), greater increase in exercise peak systolic blood pressure from VVI to DDD mode (21 ± 12 vs 4 ± 13 mm Hg, p = 0.02) and greater improvement in exercise capacity from VVI to DDD pacing (2.2 ± 1.2 vs 0.6 ± 1.4 minutes, p = 0.03) compared with the other 11 patients. A native sinus rate of <60 beats/min or VA conduction was found in 7 of the 8 patients who crossed over, but in only 1 of the 11 patients who tolerated long-term VVI pacing (p = 0.009).
AB - To identify better those subgroups of pacemaker recipients who will benefit from dual chamber pacing, 19 patients with DDD pacemakers that were physiologically paced were entered into a blinded, randomized protocol comparing long-term VVI versus DDD pacing. Patients were evaluated in each of the pacing modes for exercise performance, cardiac chamber size, cardiac output, functional status and health perception. Eight patients (42%) insisted on early crossover, from VVI to DDD pacing, after only 1.8 ± 1.4 weeks because of symptoms consistent with pacemaker syndrome. Overall, 12 patients preferred DDD pacing and no patient preferred VVI pacing (p = 0.001). Percent fractional shortening (30 ± 8 vs 24 ± 6%, p = 0.009) and cardiac output (6.3 ± 2.6 vs 4.4 ± 2.2 liters/min, p = 0.0001) where significantly greater in the DDD mode. Exercise duration was greater during DDD compared with VVI pacing (11.3 ± 3.7 vs 10.1 ±3.7 minutes, p = 0.006). However, it was only in the crossover subgroup that DDD pacing resulted in significant improvement in exercise performance and health perception compared with VVI pacing. This subgroup of patients was characterized by an intrinsic sinus rate of <60 beats/min (4/8 vs 0/11, p = 0.006), ventriculoatrial (VA) conduction (4/8 vs 1/11, p = 0.048), greater increase in exercise peak systolic blood pressure from VVI to DDD mode (21 ± 12 vs 4 ± 13 mm Hg, p = 0.02) and greater improvement in exercise capacity from VVI to DDD pacing (2.2 ± 1.2 vs 0.6 ± 1.4 minutes, p = 0.03) compared with the other 11 patients. A native sinus rate of <60 beats/min or VA conduction was found in 7 of the 8 patients who crossed over, but in only 1 of the 11 patients who tolerated long-term VVI pacing (p = 0.009).
UR - http://www.scopus.com/inward/record.url?scp=0023719996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023719996&partnerID=8YFLogxK
U2 - 10.1016/0002-9149(88)90938-1
DO - 10.1016/0002-9149(88)90938-1
M3 - Article
C2 - 3341209
AN - SCOPUS:0023719996
VL - 61
SP - 323
EP - 329
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 4
ER -